Pictet Asset Management
RVMD icon

Pictet Asset Management’s Revolution Medicines RVMD Stock Holding History

Pictet Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191M Buy
1,014,894
+457,334
+82% +$66.8M 0.18% 138
2026
Q1 		$53.6M Sell
557,560
-579,561
-51% -$58.5M 0.06% 301
2025
Q4 		$90.7M Sell
1,137,121
-174,620
-13% -$11.4M 0.09% 235
2025
Q3 		$61.2M Buy
1,311,741
+299,781
+30% +$11.7M 0.06% 284
2025
Q2 		$37.2M Buy
1,011,960
+264,400
+35% +$10.2M 0.04% 368
2025
Q1 		$26.4M Buy
747,560
+34,964
+5% +$1.42M 0.03% 424
2024
Q4 		$31.2M Buy
712,596
+696,759
+4,400% +$35.2M 0.03% 389
2024
Q3 		$717K Buy
15,837
+1,050
+7% +$45.7K ﹤0.01% 1189
2024
Q2 		$574K Buy
14,787
+2,255
+18% +$84.3K ﹤0.01% 1218
2024
Q1 		$404K Buy
+12,532
New +$371K ﹤0.01% 1400

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Pictet Asset Management's RVMD Position: Q2 2026 in Review

Pictet Asset Management increased its Revolution Medicines (RVMD) stake by 82% in Q2 2026, buying an estimated $66.8M and bringing the position to 1,014,894 shares worth $191M. The position accounts for 0.18% of the portfolio, ranked #138.

Pictet Asset Management first reported a position in RVMD in Q1 2024 and has held it in 10 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Pictet Asset Management held 1,014,894 shares of Revolution Medicines worth $191M as of Q2 2026.
  • Pictet Asset Management bought 457,334 Revolution Medicines shares in Q2 2026, an estimated $66.8M.
  • Revolution Medicines made up 0.18% of Pictet Asset Management's portfolio in Q2 2026, its #138 holding.
  • Pictet Asset Management first reported a position in Revolution Medicines in Q1 2024 and has held it in 10 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.